Evaluation of Tissue Apposition and Seroma Prevention in an Ovine Model of Surgical Dead Space Using a Novel Air-Purged Vacuum Closure System.

Eplasty Pub Date : 2022-10-12 eCollection Date: 2022-01-01
Isaac Tt Mason, Hamish J Rose, Sarah F Williamson, Alister T Jowsey, Sean J Gorman, Henry D Chittock, Christopher Ch Wong, Anish J Dheda, Samuel B Turner, Young Eun Park, Tarek Kollmetz, Jenny M Sonis, J Lacy Kamm, Barnaby Ch May
{"title":"Evaluation of Tissue Apposition and Seroma Prevention in an Ovine Model of Surgical Dead Space Using a Novel Air-Purged Vacuum Closure System.","authors":"Isaac Tt Mason,&nbsp;Hamish J Rose,&nbsp;Sarah F Williamson,&nbsp;Alister T Jowsey,&nbsp;Sean J Gorman,&nbsp;Henry D Chittock,&nbsp;Christopher Ch Wong,&nbsp;Anish J Dheda,&nbsp;Samuel B Turner,&nbsp;Young Eun Park,&nbsp;Tarek Kollmetz,&nbsp;Jenny M Sonis,&nbsp;J Lacy Kamm,&nbsp;Barnaby Ch May","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Postoperative complications associated with seroma formation resulting from surgical dead space continue to present a challenge in modern surgery. There is an unmet need for new technologies that address surgical dead space as well as prevent seroma formation and associated downstream postoperative complications.</p><p><strong>Methods: </strong>The novel implantable tissue apposition and drainage system ENIVO was developed and tested in a bilateral ovine external abdominal oblique (EAO) resection model of surgical dead space. The ENIVO system is a portable powered pump and wound interface featuring air-purged vacuum closure (APVC) that delivers a sustained level of vacuum pressure (80 and 100 mmHg) to the treatment site with an intermittent burst of sterile filtered air through the implanted wound interface. Seroma area, seroma volume, and drain migration were assessed at postoperative days 7 and 14, and all animals were euthanized at day 28 with gross assessment of treatment efficacy including the presence of residual seroma and tissue apposition.</p><p><strong>Results: </strong>The bilateral model created relatively uniform defects of ~120 cm<sup>2</sup> following excision of ~30 to 50 g of EAO muscle. Median seroma area of ENIVO-treated defects was statistically smaller than standard of care (SoC)-treated defects at days 7 and 14. Median seroma volume at 14 days was significantly reduced in ENIVO-treated defects relative to SoC-treated defects [1.3 (IQR 0.0-79.5) mL and 188.5 (IQR 27.6-342.9) mL, respectively]. At postoperative day 28, 40% (n = 4/10) of SoC defects showed a residual seroma, whereas in contrast, none of the ENIVO-treated defects showed signs of a residual seroma. Median tissue apposition scoring was higher in the ENIVO treatment group [3 (IQR 3-3)] compared with the SoC group [3 (IQR 0-3)].</p><p><strong>Conclusions: </strong>The ENIVO system represents a new approach to dead space management and seroma prevention and was shown to outperform a SoC surgical drain in a challenging large defect model of surgical dead space management and seroma prevention.</p>","PeriodicalId":11687,"journal":{"name":"Eplasty","volume":" ","pages":"e46"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643872/pdf/eplasty-22-e46.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eplasty","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Postoperative complications associated with seroma formation resulting from surgical dead space continue to present a challenge in modern surgery. There is an unmet need for new technologies that address surgical dead space as well as prevent seroma formation and associated downstream postoperative complications.

Methods: The novel implantable tissue apposition and drainage system ENIVO was developed and tested in a bilateral ovine external abdominal oblique (EAO) resection model of surgical dead space. The ENIVO system is a portable powered pump and wound interface featuring air-purged vacuum closure (APVC) that delivers a sustained level of vacuum pressure (80 and 100 mmHg) to the treatment site with an intermittent burst of sterile filtered air through the implanted wound interface. Seroma area, seroma volume, and drain migration were assessed at postoperative days 7 and 14, and all animals were euthanized at day 28 with gross assessment of treatment efficacy including the presence of residual seroma and tissue apposition.

Results: The bilateral model created relatively uniform defects of ~120 cm2 following excision of ~30 to 50 g of EAO muscle. Median seroma area of ENIVO-treated defects was statistically smaller than standard of care (SoC)-treated defects at days 7 and 14. Median seroma volume at 14 days was significantly reduced in ENIVO-treated defects relative to SoC-treated defects [1.3 (IQR 0.0-79.5) mL and 188.5 (IQR 27.6-342.9) mL, respectively]. At postoperative day 28, 40% (n = 4/10) of SoC defects showed a residual seroma, whereas in contrast, none of the ENIVO-treated defects showed signs of a residual seroma. Median tissue apposition scoring was higher in the ENIVO treatment group [3 (IQR 3-3)] compared with the SoC group [3 (IQR 0-3)].

Conclusions: The ENIVO system represents a new approach to dead space management and seroma prevention and was shown to outperform a SoC surgical drain in a challenging large defect model of surgical dead space management and seroma prevention.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
利用新型空气净化真空封闭系统评估绵羊手术死腔模型的组织附着和血清肿预防。
背景:手术死腔导致的血肿并发症在现代外科手术中仍然是一个挑战。对于解决手术死腔以及预防血清肿形成和相关的术后并发症的新技术的需求尚未得到满足。方法:在双侧羊腹外斜(EAO)手术死腔切除模型上,研制了一种新型的可植入组织旁置引流系统ENIVO。ENIVO系统是一种便携式动力泵和伤口界面,具有空气净化真空封闭(APVC)功能,可通过植入伤口界面间歇爆发无菌过滤空气,向治疗部位提供持续的真空压力(80和100 mmHg)。在术后第7天和第14天评估血肿面积、血肿体积和引流液迁移,并在第28天对所有动物实施安乐死,并对治疗效果进行总体评估,包括是否存在残留血肿和组织附着。结果:双侧模型在切除~30 ~ 50 g EAO肌后形成了~120 cm2的相对均匀的缺损。在第7天和第14天,enivo治疗缺陷的中位血肿面积在统计学上小于标准护理(SoC)治疗的缺陷。与soc处理的缺陷相比,enivo处理的缺陷14天的中位血肿体积显著减少[分别为1.3 (IQR 0.0-79.5) mL和188.5 (IQR 27.6-342.9) mL]。术后28天,40% (n = 4/10)的SoC缺陷显示残留血肿,而相比之下,所有经enivo治疗的缺陷均未显示残留血肿迹象。ENIVO治疗组的中位组织旁位评分[3 (IQR 3-3)]高于SoC组[3 (IQR 0-3)]。结论:ENIVO系统代表了一种新的死亡空间管理和血肿预防方法,在具有挑战性的手术死亡空间管理和血肿预防的大缺陷模型中,ENIVO系统被证明优于SoC手术引流。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Does Size Really Matter? A Review on How to Determine the Optimal Umbilical Size During an Abdominoplasty. The 5 D's to Dunk the Dog: A Retrospective Clinical Review to Prevent Dog-Ear Contour Abnormalities in Vertical Breast Reductions and Breast Lifts. Beneficial Impact of "Supercharged" Pectoralis Major Musculocutaneous Flap With Indocyanine Green Angiography on Reconstruction in a Patient at High Risk for Necrosis. The Safety of Long Inframammary Fold to Nipple Lengths in Inferior Pedicle Breast Reductions: A Decade of Experience. Are Large Intraoperative Fill Volumes Associated With Increased Complications After Tissue Expander Placement?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1